Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Jul;56(1):59–63. doi: 10.1038/bjc.1987.154

Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).

A N Stark, J Thorogood, C Head, B E Roberts, C S Scott
PMCID: PMC2001685  PMID: 3476144

Abstract

Ninety-seven cases of chronic myelomonocytic leukaemia (CMML) were examined retrospectively for survival and possible prognostic factors including age, total white cell count, peripheral blood and bone marrow monocyte counts, % double esterase (DE) positive cells in bone marrow and serum lysozyme. Age, absolute monocyte counts and serum lysozyme proved to be significant independent prognostic indicators but Cox model analyses showed serum lysozyme to be the most important factor whether taken as a continuous or discrete (two groups) variable. Twelve cases of second malignancy were found, including 2 cases of multiple myeloma, but this was not significantly greater than expected when compared with an age and sex matched group.

Full text

PDF
59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessandrino E. P., Orlandi E., Brusamolino E., Lazzarino M., Morra E., Castagnola C., Bernasconi C. Chronic myelomonocytic leukemia: clinical features, cytogenetics, and prognosis in 30 consecutive cases. Hematol Oncol. 1985 Apr-Jun;3(2):147–155. doi: 10.1002/hon.2900030206. [DOI] [PubMed] [Google Scholar]
  2. Altman A. J., Palmer C. G., Baehner R. L. Juvenile "chronic granulocytic" leukemia: a panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood. 1974 Mar;43(3):341–350. [PubMed] [Google Scholar]
  3. Barnard D. L., Burns G. F., Gordon J., Cawley J. C., Barker C. R., Hayhoe F. G., Smith J. L. Chronic myelomonocytic leukemia with paraproteinemia but no detectable plasmacytosis: a detailed cytological and immunological study. Cancer. 1979 Sep;44(3):927–936. doi: 10.1002/1097-0142(197909)44:3<927::aid-cncr2820440321>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  4. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189–199. [PubMed] [Google Scholar]
  5. Broun G. O., Jr Chronic erythromonocytic leukemia. Am J Med. 1969 Nov;47(5):785–796. doi: 10.1016/0002-9343(69)90171-5. [DOI] [PubMed] [Google Scholar]
  6. Copplestone J. A., Mufti G. J., Hamblin T. J., Oscier D. G. Immunological abnormalities in myelodysplastic syndromes. II. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. Br J Haematol. 1986 May;63(1):149–159. doi: 10.1111/j.1365-2141.1986.tb07505.x. [DOI] [PubMed] [Google Scholar]
  7. Geary C. G., Catovsky D., Wiltshaw E., Milner G. R., Scholes M. C., Van Noorden S., Wadsworth L. D., Muldal S., MacIver J. E., Galton D. A. Chronic myelomonocytic leukaemia. Br J Haematol. 1975 Jul;30(3):289–302. doi: 10.1111/j.1365-2141.1975.tb00544.x. [DOI] [PubMed] [Google Scholar]
  8. Haznedar R. Pancytopenia with a hypercellular bone marrow as a possible paraneoplastic syndrome. Am J Hematol. 1985 Jun;19(2):205–206. doi: 10.1002/ajh.2830190214. [DOI] [PubMed] [Google Scholar]
  9. Ho A. D., Fiehn W., Hunstein W. Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma. Br J Haematol. 1982 Apr;50(4):637–645. doi: 10.1111/j.1365-2141.1982.tb01964.x. [DOI] [PubMed] [Google Scholar]
  10. Linman J. W. Myelomonocytic leukemia and its preleukemic phase. J Chronic Dis. 1970 Apr;22(11):713–716. doi: 10.1016/0021-9681(70)90046-9. [DOI] [PubMed] [Google Scholar]
  11. Miescher P. A., Farguet J. J. Chronic myelomonocytic leukemia in adults. Semin Hematol. 1974 Apr;11(2):129–139. [PubMed] [Google Scholar]
  12. Milligan D. W., Roberts B. E., Limbert H. J., Jalihal S., Scott C. S. Cytochemical and immunological characteristics of acute monocytic leukaemia. Br J Haematol. 1984 Nov;58(3):391–397. doi: 10.1111/j.1365-2141.1984.tb03986.x. [DOI] [PubMed] [Google Scholar]
  13. Milner G. R., Testa N. G., Geary C. G., Dexter T. M., Muldal S., MacIver J. E., Lajtha L. G. Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'. Br J Haematol. 1977 Feb;35(2):251–261. doi: 10.1111/j.1365-2141.1977.tb00582.x. [DOI] [PubMed] [Google Scholar]
  14. Mufti G. J., Hamblin T. J., Clein G. P., Race C. Coexistent myelodysplasia and plasma cell neoplasia. Br J Haematol. 1983 May;54(1):91–96. doi: 10.1111/j.1365-2141.1983.tb02070.x. [DOI] [PubMed] [Google Scholar]
  15. Raz I., Shinar E., Polliack A. Pancytopenia with hypercellular bone marrow--a possible paraneoplastic syndrome in carcinoma of the lung: a report of three cases. Am J Hematol. 1984 May;16(4):403–408. doi: 10.1002/ajh.2830160411. [DOI] [PubMed] [Google Scholar]
  16. Saarni M. I., Linman J. W. Myelomonocytic leukemia: disorderly proliferation of all marrow cells. Cancer. 1971 May;27(5):1221–1230. doi: 10.1002/1097-0142(197105)27:5<1221::aid-cncr2820270530>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  17. Sans-Sabrafen J., Woessner S., Besses C., Lafuente R., Florensa L., Buxó J. Association of chronic myelomonocytic leukemia and carcinoma: a possible paraneoplastic myelodysplasia. Am J Hematol. 1986 May;22(1):109–110. doi: 10.1002/ajh.2830220116. [DOI] [PubMed] [Google Scholar]
  18. Scott C. S., Cahill A., Bynoe A. G., Ainley M. J., Hough D., Roberts B. E. Esterase cytochemistry in primary myelodysplastic syndromes and megaloblastic anaemias: demonstration of abnormal staining patterns associated with dysmyelopoiesis. Br J Haematol. 1983 Nov;55(3):411–418. doi: 10.1111/j.1365-2141.1983.tb02155.x. [DOI] [PubMed] [Google Scholar]
  19. Scott C. S., Cahill A., Morgan M., Roberts B. E. Double esterase positive cells. Br J Haematol. 1984 Dec;58(4):762–764. doi: 10.1111/j.1365-2141.1984.tb06124.x. [DOI] [PubMed] [Google Scholar]
  20. Scott C. S., Davey M., Hamilton A., Norfolk D. R. Serum enzyme concentrations in untreated acute myeloid leukaemia. Blut. 1986 May;52(5):297–303. doi: 10.1007/BF00320793. [DOI] [PubMed] [Google Scholar]
  21. Scott C. S., Morgan M., Limbert H. J., MacKarill I. D., Roberts B. E. Cytochemical, immunological and ANAE-isoenzyme studies in acute myelomonocytic leukaemia: a study of 39 cases. Scand J Haematol. 1985 Sep;35(3):284–291. doi: 10.1111/j.1600-0609.1985.tb01707.x. [DOI] [PubMed] [Google Scholar]
  22. Sexauer J., Kass L., Schnitzer B. Subacute myelomonocytic leukemia. Clinical, morphologic and ultrastructural studies of 10 cases. Am J Med. 1974 Dec;57(6):853–861. doi: 10.1016/0002-9343(74)90161-2. [DOI] [PubMed] [Google Scholar]
  23. Solal-Celigny P., Desaint B., Herrera A., Chastang C., Amar M., Vroclans M., Brousse N., Mancilla F., Renoux M., Bernard J. F. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984 Mar;63(3):634–638. [PubMed] [Google Scholar]
  24. Stefanini M. Enzymes, isozymes, and enzyme variants in the diagnosis of cancer. A short review. Cancer. 1985 May 1;55(9):1931–1936. doi: 10.1002/1097-0142(19850501)55:9<1931::aid-cncr2820550917>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  25. Thomas W. J., North R. B., Poplack D. G., Slease R. B., Duval-Arnould B. Chronic myelomonocytic leukemia in childhood. Am J Hematol. 1981;10(2):181–194. doi: 10.1002/ajh.2830100210. [DOI] [PubMed] [Google Scholar]
  26. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES